STAT
@statnews
Reporting from the frontiers of health & medicine.
Sign up for any of our newsletters here:
Joined July 2015
4.7K Following 165.3K Followers
The FDA flagged a potential safety signal after four patient deaths in a trial testing a schizophrenia drug, Argenx faces an unusual setback, and more pharma news.
